Abstract
This chapter is focused on the changes in the metabolic pathways of immune cells to fulfill the demands of development, proliferation, and effector function of T-cells.
We review how T-cells change their metabolism to (a) obtain energy throughout the different states of maturation (naive, memory, and effector cell), (b) form construction blocks to proliferate (carbon skeleton and nitrogen for nitrogen bases), and (c) live during a long-term period. Finally, we also review how the metabolism of T-cell is affected by the tumor microenvironment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Cui W, Kaech SM. Generation of effector CD8+ T cells and their conversion to memory T cells. Immunol Rev. 2010;236:151–66. https://doi.org/10.1111/j.1600-065X.2010.00926.x.
Bengsch B, Johnson AL, Kurachi M, et al. Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion. Immunity. 2016;45:358–73. https://doi.org/10.1016/j.immuni.2016.07.008.
Lefrancois L. Development, trafficking, and function of memory T-cell subsets. Immunol Rev. 2006;211:93–103. https://doi.org/10.1111/j.0105-2896.2006.00393.x.
Appay V, van Lier RA, Sallusto F, Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A. 2008;73:975–83. https://doi.org/10.1002/cyto.a.20643.
Belz GT, Kallies A. Effector and memory CD8+ T cell differentiation: toward a molecular understanding of fate determination. Curr Opin Immunol. 2010;22:279–85. https://doi.org/10.1016/j.coi.2010.03.008.
Mahnke YD, Brodie TM, Sallusto F, Roederer M, Lugli E. The who’s who of T-cell differentiation: human memory T-cell subsets. Eur J Immunol. 2013;43:2797–809. https://doi.org/10.1002/eji.201343751.
Jones RG, Thompson CB. Revving the engine: signal transduction fuels T cell activation. Immunity. 2007;27:173–8. https://doi.org/10.1016/j.immuni.2007.07.008.
Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS, Jones RG, Choi Y. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 2009;460:103–7. https://doi.org/10.1038/nature08097.
Sukumar M, Liu J, Ji Y, et al. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J Clin Invest. 2013;123:4479–88. https://doi.org/10.1172/jci69589.
Ho PC, Bihuniak JD, Macintyre AN, et al. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T-cell responses. Cell. 2015;162:1217–28. https://doi.org/10.1016/j.cell.2015.08.012.
van der Windt GJ, O’Sullivan D, Everts B, et al. CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability. Proc Natl Acad Sci U S A. 2013;110:14336–41. https://doi.org/10.1073/pnas.1221740110.
Jones N, Cronin JG, Dolton G, et al. Metabolic adaptation of human CD4(+) and CD8(+) T-cells to T-cell receptor-mediated stimulation. Front Immunol. 2017;8:1516. https://doi.org/10.3389/fimmu.2017.01516.
Yin Y, Choi SC, Xu Z, Zeumer L, Kanda N, Croker BP, Morel L. Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus. J Immunol. 2016;196:80–90. https://doi.org/10.4049/jimmunol.1501537.
Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci U S A. 2005;102:8204–9. https://doi.org/10.1073/pnas.0502857102.
Tomida T, Hirose K, Takizawa A, Shibasaki F, Iino M. NFAT functions as a working memory of Ca2+ signals in decoding Ca2+ oscillation. EMBO J. 2003;22:3825–32. https://doi.org/10.1093/emboj/cdg381.
He S, Kato K, Jiang J, Wahl DR, Mineishi S, Fisher EM, Murasko DM, Glick GD, Zhang Y. Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cells. PLoS One. 2011;6:e20107. https://doi.org/10.1371/journal.pone.0020107.
Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu Rev Immunol. 2007;25:171–92. https://doi.org/10.1146/annurev.immunol.25.022106.141548.
D’Souza AD, Parikh N, Kaech SM, Shadel GS. Convergence of multiple signaling pathways is required to coordinately up-regulate mtDNA and mitochondrial biogenesis during T cell activation. Mitochondrion. 2007;7:374–85. https://doi.org/10.1016/j.mito.2007.08.001.
Chang CH, Curtis JD, Maggi LB Jr, et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 2013;153:1239–51. https://doi.org/10.1016/j.cell.2013.05.016.
Tripmacher R, Gaber T, Dziurla R, et al. Human CD4(+) T cells maintain specific functions even under conditions of extremely restricted ATP production. Eur J Immunol. 2008;38:1631–42. https://doi.org/10.1002/eji.200738047.
O’Sullivan D, van der Windt GJ, Huang SC, et al. Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity. 2014;41:75–88. https://doi.org/10.1016/j.immuni.2014.06.005.
Shen Y, Wen Z, Li Y, Matteson EL, Hong J, Goronzy JJ, Weyand CM. Metabolic control of the scaffold protein TKS5 in tissue-invasive, proinflammatory T cells. Nat Immunol. 2017;18:1025–34. https://doi.org/10.1038/ni.3808.
Muroski ME, Miska J, Chang AL, Zhang P, Rashidi A, Moore H, Lopez-Rosas A, Han Y, Lesniak MS. Fatty acid uptake in T cell subsets using a quantum dot fatty acid conjugate. Sci Rep. 2017;7:5790. https://doi.org/10.1038/s41598-017-05556-x.
Henson SM, Lanna A, Riddell NE, et al. p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8(+) T cells. J Clin Invest. 2014;124:4004–16. https://doi.org/10.1172/jci75051.
van der Windt GJ, Everts B, Chang CH, Curtis JD, Freitas TC, Amiel E, Pearce EJ, Pearce EL. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity. 2012;36:68–78. https://doi.org/10.1016/j.immuni.2011.12.007.
Buck MD, O’Sullivan D, Klein Geltink RI, et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell. 2016;166:63–76. https://doi.org/10.1016/j.cell.2016.05.035.
Chang CH, Qiu J, O’Sullivan D, et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell. 2015;162:1229–41. https://doi.org/10.1016/j.cell.2015.08.016.
Schurich A, Pallett LJ, Jajbhay D, et al. Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host. Cell Rep. 2016;16:1243–52. https://doi.org/10.1016/j.celrep.2016.06.078.
Patsoukis N, Bardhan K, Chatterjee P, et al. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun. 2015;6:6692. https://doi.org/10.1038/ncomms7692.
Parry RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, Kobayashi SV, Linsley PS, Thompson CB, Riley JL. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol. 2005;25:9543–53. https://doi.org/10.1128/mcb.25.21.9543-9553.2005.
Duvel K, Yecies JL, Menon S, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010;39:171–83. https://doi.org/10.1016/j.molcel.2010.06.022.
Angelin A, Gil-de-Gomez L, Dahiya S, et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 2017;25:1282–93.e7. https://doi.org/10.1016/j.cmet.2016.12.018.
Aguilar-Cazares D, Meneses-Flores M, Prado-Garcia H, Islas-Vazquez L, Rojo-Leon V, Romero-Garcia S, Rivera-Rosales RM, Lopez-Gonzalez JS. Relationship of dendritic cell density, HMGB1 expression, and tumor-infiltrating lymphocytes in non-small cell lung carcinomas. Appl Immunohistochem Mol Morphol. 2014;22:105–13. https://doi.org/10.1097/PAI.0b013e3182849808.
Denkert C, von Minckwitz G, Darb-Esfahani S, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2017;19(1):P40–50. https://doi.org/10.1016/s1470-2045(17)30904-x.
Jakubowska K, Kisielewski W, Kanczuga-Koda L, Koda M, Famulski W. Stromal and intraepithelial tumor-infiltrating lymphocytes in colorectal carcinoma. Oncol Lett. 2017;14:6421–32. https://doi.org/10.3892/ol.2017.7013.
Yagi T, Baba Y, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Baba H. PD-L1 expression, tumor-infiltrating lymphocytes, and clinical outcome in patients with surgically resected esophageal cancer. Ann Surg. 2019;269(3):471–8. https://doi.org/10.1097/sla.0000000000002616.
Nakagawa Y, Negishi Y, Shimizu M, Takahashi M, Ichikawa M, Takahashi H. Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes. Immunol Lett. 2015;167:72–86. https://doi.org/10.1016/j.imlet.2015.07.003.
Caldwell CC, Kojima H, Lukashev D, Armstrong J, Farber M, Apasov SG, Sitkovsky MV. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol. 2001;167:6140–9.
Cretenet G, Clerc I, Matias M, et al. Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions. Sci Rep. 2016;6:24129. https://doi.org/10.1038/srep24129.
Brand A, Singer K, Koehl GE, et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 2016;24:657–71. https://doi.org/10.1016/j.cmet.2016.08.011.
Fischer K, Hoffmann P, Voelkl S, et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007;109:3812–9. https://doi.org/10.1182/blood-2006-07-035972.
Siska PJ, Beckermann KE, Mason FM, et al. Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight. 2017;2:93411. https://doi.org/10.1172/jci.insight.93411.
Haas R, Smith J, Rocher-Ros V, et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol. 2015;13:e1002202. https://doi.org/10.1371/journal.pbio.1002202.
Acknowledgements
This work was supported by the Consejo Nacional de Ciencia y Tecnología (CONACYT), grant CB-2013-219932.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Prado-Garcia, H., Sandoval-Martinez, R., Romero-Garcia, S. (2020). T-Cell Metabolism and Its Dysfunction Induced by Cancer. In: Rezaei, N. (eds) Cancer Immunology. Springer, Cham. https://doi.org/10.1007/978-3-030-30845-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-30845-2_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30844-5
Online ISBN: 978-3-030-30845-2
eBook Packages: MedicineMedicine (R0)